Concepedia

Sigrid Ring

SR

Statistics

Publications

16

Citations

2.4K

H-Index

15

Active since

1987

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas System

Sigrid Ring is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, chemotherapy, and medicine.

Publications per year

1987–2009

16

Publications

16

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Nuhad K. Ibrahim, Neil Desai, Sewa S. Legha et al. · PubMed · 2002 · 630 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

Omar Eton, Sewa S. Legha, Agop Y. Bedikian et al. · Journal of Clinical Oncology · 2002 · 376 citations

Medicine, Oncology, Pharmacology +13

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

S S Legha, Sigrid Ring, Omar Eton et al. · Journal of Clinical Oncology · 1998 · 293 citations

Medicine, Oncology, Pharmacotherapy +14

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

Omar Eton, S S Legha, T E Moon et al. · Journal of Clinical Oncology · 1998 · 221 citations

Medicine, Clinical Sciences, Oncology +17

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

Sewa S. Legha, Sigrid Ring, Carl Plager et al. · Cancer · 1989 · 178 citations

Medicine, Oncology, Pharmacology +12

1–5 of 16